Pulmonary arterial hypertension associated with another disease Advocacy Hub | UniteRare

At a Glance

Live from database

💊

5FDA treatments

💰

2Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Pulmonary arterial hypertension associated with another disease.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs2

OTEZLAï¿½

Amgen Inc.

OpenContact for detailsApply ↗

Ingrezza

Neurocrine Biosciences Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

5 FDA-approved

Acetylcysteine

(ACETYLCYSTEINE)Orphan drugstandard

Hospira, Inc.

FDA label ↗

Ingrezza

(valbenazine)Orphan drugstandard

Neurocrine Biosciences Inc.

12.1 Mechanism of Action The mechanism of action of valbenazine for the treatment of tardive dyskinesia and chorea in patients with Huntington’s disea...

FDA label ↗

Tyvaso DPI

(treprostinil inhalation powder)Orphan drugstandard

United Therapeutics Corporation

Prostacycline Vasodilator [EPC]

12.1 Mechanism of Action Treprostinil is a prostacyclin analogue. The major pharmacologic actions of treprostinil are direct vasodilation of pulmonary...

FDA label ↗

OTEZLAï¿½

(apremilast)Orphan drugstandard

Amgen Inc.

Phosphodiesterase 4 Inhibitor [EPC]

12.1 Mechanism of Action Apremilast is an oral small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine monophosphate (cAM...

FDA label ↗

Tyvaso

(treprostinil)Orphan drugstandard

United Therapeutics

Prostacycline Vasodilator [EPC]

12.1 Mechanism of Action Treprostinil is a prostacyclin analogue. The major pharmacologic actions of treprostinil are direct vasodilation of pulmonary...

FDA label ↗

View full treatment details on disease page →